Details for New Drug Application (NDA): 063239
✉ Email this page to a colleague
NDA 063239 describes ROCEPHIN, which is a drug marketed by Hoffmann La Roche and Roche and is included in five NDAs. Additional details are available on the ROCEPHIN profile page.
The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
Summary for 063239
| Tradename: | ROCEPHIN |
| Applicant: | Hoffmann La Roche |
| Ingredient: | ceftriaxone sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063239
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/VIAL | ||||
| Approval Date: | Aug 13, 1993 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Aug 13, 1993 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Aug 13, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
